ATE476962T1 - Nichtwässrige flüssige parenterale aceclofenac- formulierung - Google Patents

Nichtwässrige flüssige parenterale aceclofenac- formulierung

Info

Publication number: ATE476962T1
Authority: AT; Austria
Prior art keywords: aceclofenac; disclosed; formulation; conversion; storage
Prior art date: 2004-11-22

Application number

AT05808069T

Other languages

English (en)

Inventor

Manu Chaudhary

Original Assignee

Venus Remedies Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-22

Filing date

2005-10-19

Publication date

2010-08-15

2005-10-19 Application filed by Venus Remedies Ltd filed Critical Venus Remedies Ltd

2010-08-15 Application granted granted Critical

2010-08-15 Publication of ATE476962T1 publication Critical patent/ATE476962T1/de

Links

MNIPYSSQXLZQLJ-UHFFFAOYSA-N Biofenac Chemical compound OC(=O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl MNIPYSSQXLZQLJ-UHFFFAOYSA-N 0.000 title abstract 7
229960004420 aceclofenac Drugs 0.000 title abstract 6
239000000203 mixture Substances 0.000 title abstract 6
238000009472 formulation Methods 0.000 title abstract 3
239000007788 liquid Substances 0.000 title abstract 3
238000000034 method Methods 0.000 abstract 3
238000006243 chemical reaction Methods 0.000 abstract 2
239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 2
229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 2
229960001259 diclofenac Drugs 0.000 abstract 1
DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 abstract 1
238000010790 dilution Methods 0.000 abstract 1
239000012895 dilution Substances 0.000 abstract 1
239000002552 dosage form Substances 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000001556 precipitation Methods 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
230000000087 stabilizing effect Effects 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

AT05808069T 2004-11-22 2005-10-19 Nichtwässrige flüssige parenterale aceclofenac- formulierung ATE476962T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN2332DE2004		2004-11-22
PCT/IN2005/000339 WO2006054315A1 (en)	2004-11-22	2005-10-19	Nonaqueous liquid parenteral aceclofenac formulation

Publications (1)

Publication Number	Publication Date
ATE476962T1 true ATE476962T1 (de)	2010-08-15

Family

ID=35636806

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05808069T ATE476962T1 (de)	2004-11-22	2005-10-19	Nichtwässrige flüssige parenterale aceclofenac- formulierung

Country Status (15)

Country	Link
US (1)	US20090156670A1 (de)
EP (1)	EP1814517B1 (de)
JP (1)	JP2008520652A (de)
KR (1)	KR20070059154A (de)
CN (1)	CN101060832A (de)
AT (1)	ATE476962T1 (de)
AU (1)	AU2005305464A1 (de)
BR (1)	BRPI0516790A (de)
DE (1)	DE602005022913D1 (de)
ES (1)	ES2350452T3 (de)
MX (1)	MX2007006106A (de)
PL (1)	PL1814517T3 (de)
PT (1)	PT1814517E (de)
SI (1)	SI1814517T1 (de)
WO (1)	WO2006054315A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20090143762A1 (en) *	2007-11-29	2009-06-04	Alltranz Inc.	Methods and Compositions for Enhancing the Viability Of Microneedle Pores
AR072777A1 (es)	2008-03-26	2010-09-22	Cephalon Inc	Formas solidas de clorhidrato de bendamustina
SMT201700043T1 (it)	2010-01-28	2017-03-08	Eagle Pharmaceuticals Inc	Formulazioni di bendamustina
US8734852B2 (en) *	2011-11-30	2014-05-27	Manu Chaudhary	Parenteral controlled release formulations of NSAID's
JP6250628B2 (ja)	2012-03-20	2017-12-20	イーグル・ファーマシューティカルズ・インコーポレーテッド	ベンダムスチンの製剤
US8828979B2 (en)	2012-03-27	2014-09-09	Essential Ingredients, Inc.	Salicylic acid gel
US20140179740A1 (en) *	2012-12-21	2014-06-26	Mylan Inc.	Stable liquid remifentanil formulations
KR101598283B1 (ko) *	2014-06-30	2016-02-29	이화여자대학교 산학협력단	안전성 및 효능이 증가된 월경통 완화 또는 치료용 복합제 조성물
MX2019000312A (es) *	2019-01-08	2019-10-09	Federico Amezcua Amezcua	Composicion farmaceutica sinergica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumaticas o dolor postquirurgico.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030060465A1 (en) *	2000-12-19	2003-03-27	Jilani Jamal A.	Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compounds
KR100425226B1 (ko) *	2001-07-03	2004-03-30	주식회사 팜트리	아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법
RU2335490C2 (ru) *	2003-02-07	2008-10-10	Оно Фармасьютикал Ко., Лтд.	Соединения карбоновой кислоты, фармацевтическая композиция на их основе, способ лечения и применение

2005
- 2005-10-19 PT PT05808069T patent/PT1814517E/pt unknown
- 2005-10-19 SI SI200531152T patent/SI1814517T1/sl unknown
- 2005-10-19 BR BRPI0516790-6A patent/BRPI0516790A/pt not_active Application Discontinuation
- 2005-10-19 WO PCT/IN2005/000339 patent/WO2006054315A1/en not_active Ceased
- 2005-10-19 MX MX2007006106A patent/MX2007006106A/es unknown
- 2005-10-19 KR KR1020077008756A patent/KR20070059154A/ko not_active Ceased
- 2005-10-19 DE DE602005022913T patent/DE602005022913D1/de not_active Expired - Lifetime
- 2005-10-19 PL PL05808069T patent/PL1814517T3/pl unknown
- 2005-10-19 JP JP2007542517A patent/JP2008520652A/ja active Pending
- 2005-10-19 CN CNA200580039565XA patent/CN101060832A/zh active Pending
- 2005-10-19 US US11/719,906 patent/US20090156670A1/en not_active Abandoned
- 2005-10-19 EP EP05808069A patent/EP1814517B1/de not_active Expired - Lifetime
- 2005-10-19 ES ES05808069T patent/ES2350452T3/es not_active Expired - Lifetime
- 2005-10-19 AT AT05808069T patent/ATE476962T1/de active
- 2005-10-19 AU AU2005305464A patent/AU2005305464A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE602005022913D1 (de)	2010-09-23
PT1814517E (pt)	2010-11-03
ES2350452T3 (es)	2011-01-24
SI1814517T1 (sl)	2010-12-31
EP1814517B1 (de)	2010-08-11
PL1814517T3 (pl)	2011-02-28
BRPI0516790A (pt)	2008-09-30
JP2008520652A (ja)	2008-06-19
KR20070059154A (ko)	2007-06-11
AU2005305464A1 (en)	2006-05-26
US20090156670A1 (en)	2009-06-18
WO2006054315B1 (en)	2006-08-17
MX2007006106A (es)	2007-10-23
CN101060832A (zh)	2007-10-24
WO2006054315A1 (en)	2006-05-26
EP1814517A1 (de)	2007-08-08

Similar Documents

Publication	Publication Date	Title
RU2740080C2 (ru)	2021-01-11	Непрерывное введение l-допа, ингибиторов допа-декарбоксилазы, ингибиторов катехол-о-метилтрансферазы и предназначенные для этого композиции
WO2009139576A3 (ko)	2010-02-11	신규 벤즈옥사졸로 치환된 피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 이상세포 성장 질환의 예방 및 치료용 약학적 조성물
EA201492021A1 (ru)	2015-02-27	Антительный состав
ATE476962T1 (de)	2010-08-15	Nichtwässrige flüssige parenterale aceclofenac- formulierung
JP2015512952A5 (de)	2016-06-09
EA201590371A1 (ru)	2015-06-30	1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний
TWI750248B (zh)	2021-12-21	含依匹斯汀之點眼液
WO2009108775A3 (en)	2009-12-03	Process to minimize polymorphism
RU2009120200A (ru)	2011-01-20	Препараты с высокими концентрациями белка, содержащие маннитол
MX2020002429A (es)	2020-07-13	Compuestos para reducir la viscosidad de las formulaciones biologicas.
RU2013113222A (ru)	2014-10-10	Способы лечения или профилактики тромбообразования или эмболии
JP2017514924A5 (de)	2018-04-26
MX2007013583A (es)	2008-03-13	Metodos y composiciones para tratar el dolor.
RU2016147362A (ru)	2018-06-13	Препараты жидкого концетрата циклофосфамида
BR112013028786A2 (pt)	2016-09-20	método e composição de tratamento de sementes
TW200639159A (en)	2006-11-16	Treatment of pain
EA200901141A1 (ru)	2010-04-30	Соли присоединения с кислотами, гидраты и полиморфные формы этидамида 5-(2,4-дигидрокси-5-изопропилфенил)-4-(4-морфолин-4-илметилфенил)изоксазол-3-карбоновой кислоты и препараты, содержащие эти формы
NZ591204A (en)	2013-02-22	Pharmaceutical compositions and methods for stabilizing the same
ATE293444T1 (de)	2005-05-15	Zusammensetzung und verfahren zur parenteralen anwendung von ibuprofen-d,l-, oder l-lysinat
CA2565993A1 (en)	2005-12-08	Salt of 4-or 5- aminosalicylic acid
NZ602126A (en)	2013-10-25	Ophthalmic Solution for Treating Ocular Infection Comprising Levofloxacin or Salt Thereof or Solvate of the Same, Method for Treating Ocular Infection, Levofloxacin or Salt Thereof or Solvate of the Same, and Use Thereof
WO2009123098A1 (ja)	2009-10-08	ガチフロキサシン含有水性液剤、その製造方法、および、該水性液剤の低温保存および凍結融解時の沈殿生成を抑制する方法
UA93365C2 (ru)	2011-02-10	Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты)
CA2726232A1 (en)	2010-08-12	Stable formulation of a therapeutic protein
WO2007144889A3 (en)	2008-06-19	Treatment of neurofibromatosis

Legal Events

Date

Code

Title

Description

2011-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1814517

Country of ref document: EP